EFFECT OF COMBINED ADMINISTRATION OF BILE DUCT DECOMPRESSION AND LACTULOSEIN MECHANICAL JAUNDICE


Cite item

Full Text

Abstract

Aim. Study the state of intestine microecology in patients with obstructive jaundice after decompression
of bile ducts and administration of lactulose. Materials and methods. 58 patients of different gender and age
who were under treatment in the 13th surgical department of City Clinical Hospital No. 7 due to obstructive
jaundice were examined. Evaluation of lactulose administration was carried out in a blinded randomized
study. The patients were divided into 2 groups of 29 individuals each: (1) patients who had undergone surgery
without administration of lactulose (control) and (2) patients who had received immediately after decompression
of bile ducts 30 ml of lactulose for 1 week (comparison group). Feces samples were obtained with a
weekly interval for bacteriological study for dysbacteriosis. Results. Based on the results of bacteriological
analysis of feces in all the 58 patients with mechanical jaundice disorders of intestine microecology of various
severity degrees were detected. In the patient group who had received lactulose for 7 days after the decompression
of bile ducts a tendency for an increase of population level of bifidobacteria and lactobacilli and a decrease
of quantity of opportunistic microorganisms of various taxonomical groups was noted. Conclusion.
Administration of lactulose to patients at 30 ml dose per day for 7 days positively affected the state of microbiocenosis
of colon towards its normalization.

About the authors

I B Rabaev

S A Bekbauov

S V Fialkina

I B Rabaev

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

S A Bekbauov

Sechenov First Moscow State Medical University, Moscow, Russia

Sechenov First Moscow State Medical University, Moscow, Russia

S V Fialkina

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

References

  1. Ардатская М.Д. Клиническое значение короткоцепочечных жирных кислот при патологии желудочно-кишечного тракта. Кремлевская медицина. 2002, 2: 21-27.
  2. Бондаренко В.М. Пребиотическое и противоинфекционное действие лактулозосодержащих препаратов. Фарматека. 2004, 11: 25-30.
  3. Бондаренко В.М., Мацулевич Т.В. Дисбактериозы кишечника как клинико-лабораторный синдром: современное состояние проблемы. М., ГЭОТАР-Медиа, 2007.
  4. Борисов А.Е., Борисова Н.А., Верховский В.С. Эндобилиарные вмешательства в лечении механической желтухи. Санкт-Петербург, Эскулап, 1997.
  5. Липницкий Е.М., Топчий С.Н. Низкомолекулярные метаболиты толстокишечной микрофлоры у больных с хирургическими заболеваниями толстой кишки. Рос. журн. гастроэнтерол. гепатол. колопроктол. 2004, 8 (1): 15-20.
  6. Маев И.B., Самсонов А.А., Плотникова Е.Ю. и др. Лактулоза (дюфалак) как важный компонент диагностики и терапии синдрома избыточного бактериального роста тонкой кишки и ассоциированной патологии органов пищеварения. Фарматека. 2010, 15: 54-61.
  7. Максимов В.И., Родоман Е.Б., Бондаренко В.М. Лактулоза и микроэкология толстой кишки. Журн. микробиол. 1998, 5: 101-107.
  8. Отраслевой стандарт Протокол ведения больных. Дисбактериоз кишечника. ОСТ 91500.11.0004-2003, Приказ МЗ РФ № 231 от 09.06.2003.
  9. Чжао А.В., Вишневский В.А. Современные принципы лечения больных с механической желтухой. Рос. гастроэнтерол. журнал. 1997, 3: 23-30.
  10. Шабунин А.В., Тарабрин В.И., Малышев И.Ю. Декомпрессия желчевыводящих путей и иммунокоррекция при хирургическом лечении механической желтухи неопухолевого генеза. Хирургия. 1998, 11: 49-51.
  11. Шаповальянц С.Г., Цкаев А.Ю., Грушко Г.В. Выбор метода декомпрессии желчных путей при механической желтухе. Аннал. хир. гепатол. 1997, 2: 117-122.
  12. Kitler M.E., Luginbuhl M., Lang O. et al. Lactitol and lactulose. An in vivo and in vitro comparison of their effects on human intestinal flora. Drug Invest. 1992, 4 (1): 73-82.
  13. Lighthouse J., Naito Y., Helmy A. et al. Endotoxinemia and benzodiazepine-like substances in compensated cirrotic patients: a randomized study comparing the effect of rifaximine alone and in association with a symbiotic preparation. Hepatol. Res. 2004, 28 (3): 155-160.
  14. Roberfroid M.B. Prebiotics: preferential substrates for specific germs? Am. J. Clin. Nutr. 2001, 73 (suppl): 406-409.
  15. Salminen S., Salminen E. Lactulose, lactic acid bacteria, intestinal microecology and mucosal protection. Scand. J. Gastroenterol. 1997, 222 (suppl): 45-48.
  16. Wigg A.J., Robert-Thompson J.G., Dymock R.B. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia and TNF-ƒ in a pathogenesis of nonalcocholic steatohepatitis. Gut.2001, 48: 206-211.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 Rabaev I.B., Bekbauov S.A., Fialkina S.V., Rabaev I.B., Bekbauov S.A., Fialkina S.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies